tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ravi Misra, 6 are a BUY (37.5%), 8 are a HOLD (50%), 2 are a SELL (12.5%).
Analyst Ravi Misra, currently employed at TRUIST, carries an average stock price target met ratio of 71.43% that have a potential upside of 19.67% achieved within 113 days.
Ravi Misra’s has documented 31 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TFX, Teleflex at 10-Aug-2026.
Analyst best performing recommendations are on NNOX (NANO X IMAGING LTD).
The best stock recommendation documented was for TDOC (TELADOC) at 11/1/2022. The price target of $33 was fulfilled within 10 days with a profit of $4.12 (14.27%) receiving and performance score of 14.27.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Feb-2025
$209
$58.18 (38.58%)
$200
2 months 4 days ago
(09-Jul-2026)
1/6 (16.67%)
$30.83 (17.30%)
99
Buy Since 04-Feb-2021
$220
$41.57 (23.30%)
$200
4 months 14 days ago
(30-Apr-2026)
8/19 (42.11%)
$43.99 (24.99%)
213
Hold Since 21-Oct-2025
$188
$9.57 (5.36%)
$169
4 months 20 days ago
(24-Apr-2026)
26/40 (65%)
$-1.61 (-0.85%)
128
Buy Since 01-May-2025
$235
$56.57 (31.70%)
$220
4 months 23 days ago
(21-Apr-2026)
18/53 (33.96%)
$39.8 (20.39%)
101
Hold Since 26-Feb-2026
$200
$21.57 (12.09%)
$200
5 months 27 days ago
(17-Mar-2026)
2/4 (50%)
$23.88 (13.56%)
42
Which stock is Ravi Misra most bullish on?
What Year was the first public recommendation made by Ravi Misra?
